A 21st Century Cures Act provision intended to help the US FDA hire and retain scientific experts likely will not be implemented for another year, further hampering the agency's efforts to fill its hundreds of vacancies.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?